Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass (Q38005896)

26 August 2017

Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass (English)

1 reference

26 August 2017

C Dirksen

1

0 references

Sten Madsbad

object named as

S Madsbad

8

0 references

Jens Juul Holst

7

object named as

J J Holst

1 reference

26 August 2017

5

D L Hansen

1 reference

26 August 2017

2

N B Jørgensen

1 reference

26 August 2017

K N Bojsen-Møller

3

1 reference

26 August 2017

S H Jacobsen

4

1 reference

26 August 2017

D Worm

6

1 reference

26 August 2017

27 April 2012

1 reference

26 August 2017

1 reference

26 August 2017

55

1 reference

26 August 2017

7

1 reference

26 August 2017

1890-1901

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-012-2556-7

26 August 2017

0 references

cites work

Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: an integrative review of early studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Trends in mortality in bariatric surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

How do we define cure of diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Gastric emptying of orally administered glucose solutions and incretin hormone responses are unaffected by laparoscopic adjustable gastric banding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Differential effect of weight loss on insulin resistance in surgically treated obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Effects of gastric bypass surgery on insulin resistance and insulin secretion in nondiabetic obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Upregulation of peroxisome proliferator-activated receptor gamma coactivator gene (PGC1A) during weight loss is related to insulin sensitivity but not to energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Increases in adiponectin predict improved liver, but not peripheral, insulin sensitivity in severely obese women during weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Changes in C-reactive protein predict insulin sensitivity in severely obese individuals after weight loss surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

The insulin tolerance test in morbidly obese patients undergoing bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Morbidly obese individuals with impaired fasting glucose have a specific pattern of insulin secretion and sensitivity: effect of weight loss after bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Early improvement in glycemic control after bariatric surgery and its relationships with insulin, GLP-1, and glucagon secretion in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Acute effect of roux-en-y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic-hyperinsulinemic clamp

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Postprandial diabetic glucose tolerance is normalized by gastric bypass feeding as opposed to gastric feeding and is associated with exaggerated GLP-1 secretion: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Improvement in ß-cell function in patients with normal and hyperglycemia following Roux-en-Y gastric bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Postprandial insulin secretion after gastric bypass surgery: the role of glucagon-like peptide 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Postprandial changes in gut regulatory peptides in gastric bypass patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Rise of oxyntomodulin in response to oral glucose after gastric bypass surgery in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

The Physiology of Glucagon-like Peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Impact of sustained weight loss achieved through Roux-en-Y gastric bypass or a lifestyle intervention on ghrelin, obestatin, and ghrelin/obestatin ratio in morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Body composition and energy metabolism following Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Regional fat changes following weight reduction from laparoscopic Roux-en-Y gastric bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Lipoprotein lipase but not hormone-sensitive lipase activities achieve normality after surgically induced weight loss in morbidly obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Gastric bypass surgery is associated with near-normal insulin suppression of lipolysis in nondiabetic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Circulating concentrations of high-molecular-weight adiponectin are increased following Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

A review of weight loss following Roux-en-Y gastric bypass vs restrictive bariatric surgery: impact on adiponectin and insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Insulin resistance: a marker of surgical stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Ileal interposition improves glucose tolerance in low dose streptozotocin-treated diabetic and euglycemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Sleeve gastrectomy with ileal transposition (SGIT) induces a significant weight loss and diabetes improvement without exclusion of the proximal intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Improvement in insulin sensitivity and β-cell function following ileal interposition with sleeve gastrectomy in type 2 diabetic patients: potential mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Short-term and mid-term control of type 2 diabetes mellitus by laparoscopic sleeve gastrectomy with ileal interposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI<30 kg/m2 (LBMI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Early changes in incretin secretion after laparoscopic duodenal-jejunal bypass surgery in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Methods for clinical assessment of insulin sensitivity and beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Gastric bypass and duodenal and gastric feeding: a comment to Hansen et al

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Dipeptidyl peptidase-4 inhibition increases portal concentrations of intact glucagon-like peptide-1 (GLP-1) to a greater extent than peripheral concentrations in anaesthetised pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

The Role of β-Cell Function and Insulin Sensitivity in the Remission of Type 2 Diabetes after Gastric Bypass Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2556-7

Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial

21 January 2018

1 reference

12 December 2020

Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery

1 reference

12 December 2020

Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms

1 reference

12 December 2020

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

1 reference

12 December 2020

Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease

1 reference

12 December 2020

Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover

1 reference

12 December 2020

Glucose utilization in morbidly obese subjects before and after weight loss by gastric bypass operation

1 reference

12 December 2020

Studies in insulin resistance following very low calorie diet and/or gastric bypass surgery

1 reference

12 December 2020

Enhanced dietary fat clearance in postobese women.

1 reference

12 December 2020

Dual mechanism for type-2 diabetes resolution after Roux-en-Y gastric bypass

1 reference

12 December 2020

Glucose clamp technique: a method for quantifying insulin secretion and resistance

1 reference

12 December 2020

Muscle insulin receptor concentrations in obese patients post bariatric surgery: relationship to hyperinsulinemia

1 reference

12 December 2020

Initial human experience with restrictive duodenal-jejunal bypass liner for treatment of morbid obesity

1 reference

12 December 2020

Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1

1 reference

12 December 2020

10.1007/S00125-012-2556-7

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

0 references

1 reference